Rock Health报告:从预测性分析走向个性化医疗

2014-11-01 MedSci MedSci原创

预测分析本身不是什么新鲜事了,亚马逊、Netflix、谷歌早以将其玩得很娴熟。从过往的数据中挖掘出关联性,最终预见未来,是其基本逻辑。预测分析在个性化医疗的重要性已经无须质疑。在医疗健康领域,事实上医生们每天都在干这样的事——观察病人的症状,将所受训练和经验用于诊断和预测最能奏效的治疗方案。让科技力量来接手医生的这项工作,更精确的计算出各种可能性的概率,从而带来个性化的诊疗服务。自2011年起,风

预测分析本身不是什么新鲜事了,亚马逊、Netflix、谷歌早以将其玩得很娴熟。从过往的数据中挖掘出关联性,最终预见未来,是其基本逻辑。预测分析在个性化医疗的重要性已经无须质疑。在医疗健康领域,事实上医生们每天都在干这样的事——观察病人的症状,将所受训练和经验用于诊断和预测最能奏效的治疗方案。让科技力量来接手医生的这项工作,更精确的计算出各种可能性的概率,从而带来个性化的诊疗服务。自2011年起,风投在此领域已有19亿的投资。这里的统计对象为以算法为主题的解决方案,例如临床决策、预防再入院、规避不良反应、疾病管理和患者匹配。


Rock Health最新发布的报告对透过基于大数据的预测性分析实现个性化医疗做了解释。


评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2015-01-17 linlin2312

    #ROC#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2015-03-02 w363522459
  3. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2015-03-29 12498dabm87暂无昵称

    #ROCK#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2015-05-06 shizhenshan

    #ALT#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2014-11-27 jawel

    个体化治疗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Sat Jan 17 16:41:00 CST 2015, time=2015-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700261, encodeId=20691e00261c7, content=<a href='/topic/show?id=ec08213328c' target=_blank style='color:#2F92EE;'>#个性化医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21332, encryptionId=ec08213328c, topicName=个性化医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16e930021335, createdName=w363522459, createdTime=Mon Mar 02 21:41:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710518, encodeId=f8871e10518a9, content=<a href='/topic/show?id=750115604e7' target=_blank style='color:#2F92EE;'>#ROCK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15604, encryptionId=750115604e7, topicName=ROCK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19831855420, createdName=12498dabm87暂无昵称, createdTime=Sun Mar 29 16:41:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860977, encodeId=fcbe18609e7e2, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed May 06 07:41:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12785, encodeId=529f12e8531, content=个体化治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7ceOChkqicg6SzjqymjoEtLx55A9HNpmV1quNDdicpmTPZp1WXCq35u64iaCjRhibmrEPN5JHdvOZt9Ajj4MxzLbJ9/0, createdBy=ddf3111026, createdName=jawel, createdTime=Thu Nov 27 21:59:00 CST 2014, time=2014-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621507, encodeId=cfce162150ed1, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Nov 03 00:41:00 CST 2014, time=2014-11-03, status=1, ipAttribution=)]
    2014-11-03 yyanpro@28cn.c

    #Health#

    0